United Kingdom · Question · Written question
HL HL3555
Respiratory Syncytial Virus: Vaccination
Introduced
17 December 2024
Last action
27 December 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 December 2024
Summary
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 6 August (HL443), what assessment they have made of the uptake of the maternal respiratory syncytial virus vaccination programme in relation to other year-round maternal
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 December 2024
Written question
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 6 August (HL443), what assessment they have made of the uptake of the maternal respiratory syncytial virus vaccination programme in relation to other year-round maternal
Source: Lords
27 December 2024
Answer
Coverage of the respiratory syncytial virus maternal vaccine programme will be measured in women who were at least 28 weeks gestation at the time of the start of the programme, and after they give birth. The first coverage data for this cohort will be pub...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-12-17/HL3555
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1750937
- uk · wq-1750937 · source updated 27 December 2024